Back to Search
ALLISON WILLIAMS, MD
MD
Family Medicine Physician
NPI: 1477545077IndividualAccepts Medicare
Specialties, Licenses & Credentials
Family Medicine PhysicianPrimary
Family Medicine
Code: 207Q00000X
D0061041(MD)
CMS Specialties
PrimaryFAMILY PRACTICE
Education
HOWARD UNIVERSITY COLLEGE OF MEDICINE
Class of 2000
Research & Publications (20)
Topiramate reduces non-convulsive seizures after focal brain ischemia in the rat.
PMID 18063309·Neurosci Lett·2008
7-preclinical
Acute and delayed neuroinflammatory response following experimental penetrating ballistic brain injury in the rat.
PMID 17605820·J Neuroinflammation·2007
4-observational
Obstructive sleep apnea, cardiovascular disease, and inflammation--is NF-kappaB the key?
PMID 17380355·Sleep Breath·2007
6-review
Interferon-gamma protects against the development of structural damage in experimental arthritis by regulating polymorphonuclear neutrophil influx into diseased joints.
PMID 17599735·Arthritis Rheum·2007
7-preclinical
Neuroprotection with the proteasome inhibitor MLN519 in focal ischemic brain injury: relation to nuclear factor kappaB (NF-kappaB), inflammatory gene expression, and leukocyte infiltration.
PMID 16759750·Neurochem Int·2006
6-review
Severity level and injury track determine outcome following a penetrating ballistic-like brain injury in the rat.
PMID 17030434·Neurosci Lett·2006
4-observational
Evaluation of gabapentin and ethosuximide for treatment of acute nonconvulsive seizures following ischemic brain injury in rats.
PMID 16728590·J Pharmacol Exp Ther·2006
7-preclinical
Recovery from ischemic brain injury in the rat following a 10 h delayed injection with MLN519.
PMID 15894077·Pharmacol Biochem Behav·2005
4-observational
Antiepileptic drug treatment of nonconvulsive seizures induced by experimental focal brain ischemia.
PMID 15140918·J Pharmacol Exp Ther·2004
7-preclinical
Delayed treatment of ischemia/reperfusion brain injury: extended therapeutic window with the proteosome inhibitor MLN519.
PMID 15060320·Stroke·2004
7-preclinical
Treatment with the snail peptide CGX-1007 reduces DNA damage and alters gene expression of c-fos and bcl-2 following focal ischemic brain injury in rats.
PMID 12955387·Exp Brain Res·2003
7-preclinical
Neuroprotection assessment by topographic electroencephalographic analysis: effects of a sodium channel blocker to reduce polymorphic delta activity following ischaemic brain injury in rats.
PMID 14703719·Fundam Clin Pharmacol·2003
4-observational
Central neuro-inflammatory gene response following soman exposure in the rat.
PMID 12951190·Neurosci Lett·2003
7-preclinical
Intrathecal CGX-1007 is neuroprotective in a rat model of focal cerebral ischemia.
PMID 11997694·Neuroreport·2002
7-preclinical
Selective NR2B NMDA receptor antagonists are protective against staurosporine-induced apoptosis.
PMID 12323394·Eur J Pharmacol·2002
7-preclinical
Neuroprotective effects of the sodium channel blocker RS100642 and attenuation of ischemia-induced brain seizures in the rat.
PMID 11911860·Brain Res·2002
7-preclinical
The suppression of rat collagen-induced arthritis and inhibition of macrophage derived mediator release by liposomal methotrexate formulations.
PMID 10858015·Inflamm Res·2000
7-preclinical
Effects of allopurinol on cardiac function and oxidant stress in chronic intermittent hypoxia.
PMID 19603215·Sleep Breath·2010
7-preclinical
Polyunsaturated fatty acids protect against prion-mediated synapse damage in vitro.
PMID 19644728·Neurotox Res·2010
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1684 VILLAGE GRN LOWR LEVEL
CROFTON, MD 21114 - Phone
- (410) 721-3822
Quick Facts
- NPI
- 1477545077
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 26
- Publications
- 20
Are you this provider?
Claim Your Profile